Cilnior Tablet

Hypertension

Oral Hypertension Adult: 5-10 mg once daily, increase to 20 mg once daily if necessary.

Cardiogenic shock; recent MI or acute unstable angina; severe aortic stenosis, heart failure. Cilnidipine is contraindicated in patients with known sensitivity to Cilnidipine or any of the excipients.

Hypotension, poor cardiac reserve, heart failure. Sudden withdrawal may exacerbate angina. During the discontinuation, the dosage should be gradually decreased under close observation. Discontinue in patients who experience ischemic pain following administration. Pregnancy, lactation.

Not Classi Cilnidipine should not be administered in pregnant woman or woman having possibilities of being pregnant. It is also advisable to avoid the administration of Cilnidipine to nursing mothers. However, if the administration is indispensable, the patient should be instructed to discontinue lactation.

Other antihypertensives; aldesleukin; antipsychotics that cause hypotension; may modify insulin and glucose responses; quinidine; carbamazepine; phenytoin; rifampicin; cimetidine; erythromycin.

Dizziness; flushing; headache; hypotension; peripheral oedema; tachycardia; palpitations; GI disturbances; increased micturition frequency; lethargy; eye pain; depression; ischaemic chest pain; cerebral or myocardial ischaemia; transient blindness; rashes; fever; abnormal liver function; gingival hyperplasia; myalgia; tremor; impotence.

Cilnidipine is a dihydropyridine calcium-channel blocker. It inhibits cellular influx of calcium, thus causing vasodilatation. It has greater selectivity for vascular smooth muscle. It has little or no action at the SA or AV nodes and -ve inotropic activity is rarely seen at therapeutic doses.

Cilnior 5 mg Tablet manufactured by Orion Pharma Ltd.. Its generic name is Cilnidipine.